References
- Longo D L, Young R C, Hubbard S M, Wesley M, Fisher R I, Jaffe E, et al. Prolonged initial remission in patients with nodular mixed lymphoma. Ann Intern Med 1984; 100: 651–656
- Ezdinli E Z, Anderson J R, Melvin F, Glick J H, Davis T E, O'Connell M J. Moderate versus aggressive chemotherapy of nodular lymphocytic poorly differentiated lymphoma. J Clin Oncol 1985; 3: 769–775
- Morgenfeld M C, Pavlovsky A, Suarez A, Somoza N, Pavlovsky S, Palau M, Barros C A. Combined cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Cancer 1975; 36: 1241–1249
- Ezdinli E Z, Costello W G, Silverstein M N, Berard C, Hartsock R J, Sokal J E. Moderate versus intensive chemotherapy of prognostically favorable non-Hodgkin's lymphoma. Cancer 1980; 46: 29–33
- Glick J H, Barnes J M, Ezdinli E Z, Berard C W, Orlow E L, Bennett J M. Nodular mixed lymphoma: results of a randomized trial failing to confirm prolonged disease-free survival with COPP chemotherapy. Blood 1981; 58: 920–925
- Liang R, Todd D, Chan T K, Chiu E, Lie A, Ho F. COPP chemotherapy for elderly patients with intermediate and high grade non-Hodgkin's lymphoma. Hematol Oncol 1993; 11: 43–50
- Physician desk reference website, Available at: http://www.pdr.net/druginformation/HomeSearchResults.aspx?SearchTerm=matulane. Accessed 10 February 2004
- Newell D, Gescher A, Harland S, Ross D, Rutty C. N-Methyl antitumour agents. A distinct class of anticancer drugs?. Cancer Chemother Pharmacol 1987; 19: 91–102
- Sigma-tau Pharmaceuticals, Available at: http://www.sigmatau.com/matulane/images/Prescribing_Information.pdf. Accessed 10 February 2006
- Maxwell M B. Reexamining the dietary restrictions with procarbazine (an MAOI). Cancer Nurs 1980; 3: 451–457
- Fisher R I, LeBlanc M, Press O W, Maloney D G, Unger J M, Miller T P. New treatment options have changed the survival of patients with follicular lymphoma. J Clin Oncol 2005; 23: 8447–8452